Navigation Links
Gene Network Sciences Names Former Wyeth President of R&D Robert Ruffolo to SAB
Date:4/28/2009

CAMBRIDGE, Mass., April 28 /PRNewswire/ -- Gene Network Sciences, Inc. today announced that it named Dr. Robert Ruffolo, former President of Wyeth Research & Development and a leader in pharmaceutical research to its Scientific Advisory Board.

Dr. Ruffolo retired as President of Wyeth Research & Development in 2008, and currently serves as a consultant to Wyeth. He had joined Wyeth in November 2000 and has been responsible for all pharmaceutical research and development (R&D) for the Company, including discovery, drug safety and metabolism, chemical and pharmaceutical development, clinical R&D and research operations. During his tenure at Wyeth, he was credited with cultivating robust research and development programs in oncology, women's health, vaccines, inflammation, cardiovascular and metabolic diseases and neuroscience, including a multi-platform effort in Alzheimer's.

Dr. Ruffolo has been recognized for his work through a number of high-profile awards. Last year, he was recognized by the Pharmaceutical Research and Manufacturers of America (PhRMA) with the 2008 Discoverer's Award for his efforts in the discovery and development of Coreg(R) while at GlaxoSmithKline. In 2006, the Wyeth Research and Development Executive Team (RADEX), formed and chaired by Dr. Ruffolo, won the Scrip Award for Management Team of the Year. Dr. Ruffolo won the George B. Koelle Award for Scientific Excellence in 2005. In 2004, IBC Conferences named him Chief Scientific Officer of the Year.

Prior to joining Wyeth, Dr. Ruffolo spent 17 years at SmithKline Beecham (now GSK) and 6 years at Lilly Research Laboratories. During his career, Dr. Ruffolo played a significant role in the discovery and/or development of a number of marketed products, including carvedilol (Coreg/Kredex) for the treatment of congestive heart failure and hypertension, dobutamine (Dobutrex) for the acute management of congestive heart failur
'/>"/>

SOURCE Gene Network Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Diversified Agency Services Network Launches TogoRun(TM), A New Global Healthcare Communications Agency
2. Insurers Administrative Corporation Joins the Availity Network
3. Anthem Blue Cross and Blue Shield and Middlesex Hospital Renew Network Agreement
4. Health Caring - A Network of Strength
5. Family Healthcare Network Selects InteGreat EHR for Deployment of Browser-Based EHR
6. Agito Networks Named to the First Annual InformationWeek Startup 50 Listing
7. Autism Support Network and Aid for Autistic Children Foundation, Inc. Create Alliance to Help Families Affected by Autism
8. DavisPTnetwork, A Professional Social Network for Physical Therapists, Reaches Over 500 Members
9. Jopari Further Expands Nationwide Medical Billing Network Connectivity for Workers Comp and Auto Providers and Payers
10. Health Choice Network Implements Sage Intergy CHC Community Health Management System and EHR Across Nation
11. Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to the Mind Research Network

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...v. 27 Allrecipes.com , the worl...g traffic numbers, with more than 2.8 million visi...r picture of what was served on the biggest food h...in 2009 weighed in at 2,225 calories per serving, ...ding to the Allrecipes site, Sweet Potato Pie I ...
(Date:11/27/2009)...nufacturers who use medical load cells at the hear... by bringing in technology partner Flintec early i...tive medical manufacturers are calling in Flintec ...ojects, ensuring that progress will not be constra...utdated technology. , (PR...
(Date:11/26/2009)... The diabetes population in the Uni...rs and annual medical spending on the disease is p... today, according to a study published in the Dece...ging Diabetes ® Program (NCDP), a program of ...from the University of Chicago. ,, According to...
(Date:11/26/2009)... lead to strains or worse , , THURSDAY, ...rong with stuffing your turkey full to bursting, b...ur suitcase as you pack for holiday trips. , Mo... hospital emergency rooms, doctors, offices, clini...d injuries, such as muscle strains, pulls and tear...
(Date:11/26/2009)... of the Live Life Again Center, a practice offerin...wing number of physicians who are taking advantag...th individuals who are interested in surgical weig... is utilizing Facebook to share before-and-after p...community. , Dallas, TX (...
Breaking Medicine News(10 mins):Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 2Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 3Health News:It's Black Friday - Time to Shop Off the Calories! Allrecipes Finds Average Thanksgiving Meal Weighed in at 2,225 Calories 4Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3
...dical, Inc. (OTC Bulletin Board: AEMD) confirmed t...te to treat the H1N1 Swine flu virus. The Hemopur...at assists the immune response in combating infect...ier(R) has previously proven effective in capturin...
... Access to Nursing Home, Assisted Living, Home Car...Zip Code Statewide , , RICHMOND, Va., April 30 ... a rate outpacing inflation, putting significant f... has led to a decline in home values and investmen...
...$0.42 - , , - Annual Guidance Narrowed to $2.05 t...nce Call Scheduled for 9 a.m. Today - , , LIONVI...Inc. (NYSE: WST ) today announced its results fo... March 31, ...
...sents First True Yellow Laser with CW-Pulse(TM) an...f., April 30 IRIDEX Corporation, (Nasdaq: IRIX ... customers of the IQ 577 laser systems. The IQ 577...tinopathy, age-related macular degeneration and gl...
...o $24.9 billion , , - GAAP earnings from continui...nd decrease 10 percent to $350 million on a non-GA...om continuing operations decline 15 percent to $0....improve the safety and productivity of health care...
...ncome , , POWAY, Calif., April 30 Digirad Corpor...ad of internal schedules on its 2009 goal of gener...low. Net income was $44,000 for the first quarter...rter. We previously communicated our 2009 goals a...
Other Medicine News:Health News:Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus 2Health News:Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus 3Health News:Aethlon Medical Confirms Hemopurifier(R) Is a Treatment Candidate Against Swine Flu Virus 4Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 2Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 3Health News:Growth in Indiana Long Term Care Costs Outpacing the Rate of Inflation, According to Annual Genworth Financial Study 4Health News:West Announces First Quarter 2009 Results 2Health News:West Announces First Quarter 2009 Results 3Health News:West Announces First Quarter 2009 Results 4Health News:West Announces First Quarter 2009 Results 5Health News:West Announces First Quarter 2009 Results 6Health News:West Announces First Quarter 2009 Results 7Health News:West Announces First Quarter 2009 Results 8Health News:West Announces First Quarter 2009 Results 9Health News:West Announces First Quarter 2009 Results 10Health News:West Announces First Quarter 2009 Results 11Health News:West Announces First Quarter 2009 Results 12Health News:West Announces First Quarter 2009 Results 13Health News:West Announces First Quarter 2009 Results 14Health News:West Announces First Quarter 2009 Results 15Health News:West Announces First Quarter 2009 Results 16Health News:West Announces First Quarter 2009 Results 17Health News:West Announces First Quarter 2009 Results 18Health News:IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems 2Health News:Cardinal Health Reports Third Quarter Results 2Health News:Cardinal Health Reports Third Quarter Results 3Health News:Cardinal Health Reports Third Quarter Results 4Health News:Cardinal Health Reports Third Quarter Results 5Health News:Cardinal Health Reports Third Quarter Results 6Health News:Cardinal Health Reports Third Quarter Results 7Health News:Cardinal Health Reports Third Quarter Results 8Health News:Cardinal Health Reports Third Quarter Results 9Health News:Cardinal Health Reports Third Quarter Results 10Health News:Cardinal Health Reports Third Quarter Results 11Health News:Cardinal Health Reports Third Quarter Results 12
(Date:11/25/2009)...., Nov. 25 The FDA granted traditi...lets, a non-nucleoside reverse transcriptase inhib...ally indicated for use in treatment-experienced ad...IV-1 strains resistant to an NNRTI and other antir...is based on 48-week data from two Phase 3 studies ...
(Date:11/25/2009)... Md., Nov. 25 Remedium ...cream-like foam that stops severe bleeding, won fi...ty Idea category of the Global Security Challenge ...cted from more than 100 entries from around the wo...e GSC Security Summit conference held at the Londo...
(Date:11/25/2009)... N.J., Nov. 25 Regado Biosciences,...of antithrombotic aptamers with active control age...ident, will be presenting at the Piper Jaffray 21s...lace Hotel in New York City. Dr. Mazzo,s presenta...ember 1 and will include an overview of the Compan...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2The Tile Doctor Launches Inaugural Product Line 14086 1The Tile Doctor Launches Inaugural Product Line 14086 2The Tile Doctor Launches Inaugural Product Line 14086 3Free Screenings During Prostate Cancer Awareness Week 57323 1Free Screenings During Prostate Cancer Awareness Week 57323 2Free Screenings During Prostate Cancer Awareness Week 57323 3Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conference 14084 1Poniard Pharmaceuticals to Present at the 2009 UBS Global Life Sciences Conference 14084 2
...s Enrolled in Clinical Trial to Assess Survival of...herapies for Unresectable Hepatocellular Carcinoma... Oncology, Inc. (LSO) today announced the completi...l of Light Infusion Therapy(TM) (Litx(TM)) as a tr...(HCC), also known as hepatoma or primary liver can...
... Pancreatic Cancer Awareness Month , , Oak Br...rointestinal Endoscopy (ASGE) and the Pancreatic C...to raise awareness about pancreatic cancer, educat...hat are available for them. , , Pancreatic ca...in the U.S. In 2008, an estimated 37,680 Americans...
Other Medicine Technology:Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6
Freedom Clear® LS External Catheters
Natural Male External Catheters
...Medical® clear, all-silicone Foley catheters e...oley catheter designs. As an inert, toxin-free ela...endable Foley catheter. Unlike silicone-coated lat...ers will not leach chemicals or water-soluble prot...
...lled-release nitrofurazone Foley catheter, RELEASE...eter is the first and only Foley that works as a d... RELEASE-NF catheter delivers the drug nitrofurazo... of the urethral tract. Unlike coated catheters, w...
Medicine Products: